Products & Services.
AMLprofiler plus the Leukostrat FLT3 Mutation Assay
The AMLprofiler is our flagship in vitro diagnostic test for AML. Now, we offer through our partnership with LabPMM the AMLprofiler plus the Leukostrat FLT3 Mutation Assay together. For more details, click here.
MMprofiler Research Service
Skyline's newest service is the MMprofiler. The MMprofiler is our microarray-based research service for Multiple Myeloma and determines 8 different clinically relevant subtypes. For more details, click here.
-
AMLprofiler
The Most Efficient Diagnosis of Acute Myeloid Leukemia.The AMLprofiler simplifies the challenging task to recognize Acute Myeloid Leukemia subtypes and make individualized therapy decisions. It delivers faster results and improved patient classification on an integrated and validated array platform.
Read more >> -
MMprofiler research service
Powerful risk stratification and genetic subtyping for multiple myeloma
Read more >>
-
-
News
-
10/02/2013 - by Skyline Diagnostics | Posted in: Events
Skyline's method for detecting CEBPA dm accepted for publication
Skyline's method for detecting CEBPA double mutations accepted for publication
Read more -
04/01/2013 - by Skyline Diagnostics | Posted in: Events
STW funds ‘Genes in space’ project
Skyline Diagnostics is proud to be a partner in the ‘Genes in space’ project, in which it will collaborate with...
Read more -
04/01/2013 - by Skyline Diagnostics | Posted in: Events
Skyline's method for detecting NPM1 mutations accepted for publication
The AMLprofiler microarray assay employs custom designed probes to detect mutations in NPM1.
Read more
-
Rotterdam Science Tower, Marconistraat 16, 3029 AK Rotterdam. The Netherlands, Europe. Phone: +31 (0)10 7038410. Fax: +31 (0)10 7043076. E-mail: info@skyline-diagnostics.com
